V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008832 | 260005836 | 1.79 | 88.2 | Curative (C) | 2014-07-22 | 2015-01-25 | Rituximab (Maintenance) | N | N | 260028694 | RITUXIMAB |
| 260008833 | 260005837 | 1.49 | 54.7 | null | 2015-10-16 | 2015-10-27 | CHOP - 21 days | null | null | 260028702 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008834 | 260005838 | 1.69 | 95 | null | 2016-10-31 | 2016-12-20 | CISPLATIN + ETOPOSIDE | N | N | 260028703 | BEAM |
| 260008835 | 260005839 | null | 69.9 | Palliative (P) | null | 2013-03-24 | Doxorubicin + Olaratumab | null | null | 260028704 | NOT MATCHED |
| 260008836 | 260005839 | 1.64 | 64.2 | Curative (C) | 2017-12-30 | 2017-12-31 | Rituximab | 02 | N | 260028704 | BENDAMUSTINE |
| 260008837 | 260005839 | 1.85 | 96.4 | Palliative (P) | 2016-10-17 | 2016-10-17 | CHOP - 21 days | 02 | N | 260028704 | ABVD |
| 260008838 | 260005839 | 1.7 | 89 | Curative (C) | 2015-06-14 | 2015-06-20 | Rituximab | N | N | 260028704 | HYDROXYCARBAMIDE |
| 260008839 | 260005839 | null | 89 | Not known (9) | 2014-04-26 | 2014-05-02 | Rituximab | N | N | 260028704 | CHLORAMBUCIL |
| 260008840 | 260005839 | 1.58 | 78.4 | Curative (C) | 2017-01-17 | 2017-01-28 | R Chlorambucil | 2 | N | 260028704 | RITUXIMAB |
| 260008841 | 260005840 | null | 82 | Curative (C) | 2016-12-26 | 2016-12-29 | Cisplatin | N | N | 260028719 | OXALIPLATIN + MDG |
| 260008842 | 260005841 | null | 76 | Curative (C) | 2015-07-16 | 2015-07-16 | RCEOP | 2 | N | 260028720 | FCR |
| 260008843 | 260005842 | 1.76 | 73 | Not known (9) | 2018-07-10 | 2018-09-04 | TIP | N | N | 260028721 | ESHAP R |
| 260008844 | 260005843 | 1.79 | 74 | Disease modification (D) | 2018-04-28 | 2018-05-02 | Cisplatin 7 day | 2 | N | 260028722 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008845 | 260012051 | 1.72 | 72.6 | Curative (C) | 2017-02-15 | 2017-02-16 | Bendamustine + prednisolone | 2 | N | 260028723 | ENZALUTAMIDE |
| 260008846 | 260005844 | null | 60 | Not known (9) | 2015-04-06 | 2015-04-16 | Rituximab (Maintenance) | 02 | N | 260028724 | IDARAM |
| 260008847 | 260005845 | 1.58 | 58.3 | Curative (C) | 2013-02-20 | 2013-02-26 | Rituximab | Y | N | 260028726 | BENDAMUSTINE |
| 260008848 | 260005845 | 1.64 | 100.5 | null | 2016-09-23 | 2016-09-23 | CHLORAMBUCIL + RITUXIMAB | Y | N | 260028726 | VINCRISTINE |
| 260008849 | 260005845 | 1.73 | 78 | Curative (C) | 2018-04-25 | 2018-04-26 | CHLORAMBUCIL + RITUXIMAB | 02 | null | 260028726 | RITUXIMAB |
| 260008850 | 260005846 | 1.65 | null | Disease modification (D) | 2015-02-08 | 2015-02-08 | CISPLATIN + ETOPOSIDE | 2 | N | 260028731 | RITUXIMAB |
| 260008851 | 260005847 | 1.73 | 90.8 | null | 2018-11-25 | 2018-11-26 | Trial Unspecified | N | N | 260028735 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008852 | 260005847 | 1.68 | 88.1 | null | 2016-05-21 | 2016-05-21 | Rituximab | 02 | null | 260028735 | RITUXIMAB |
| 260008853 | 260005848 | null | 98.7 | Curative (C) | 2016-06-29 | 2016-07-08 | Rituximab | 2 | Y | 260028743 | RITUXIMAB |
| 260008854 | 260005848 | 1.68 | 53.8 | Palliative (P) | 2014-06-28 | 2014-07-13 | GALLIUM TRIAL | N | N | 260028743 | TRIAL |
| 260008855 | 260005849 | 1.74 | 75.5 | null | 2016-04-19 | 2016-04-22 | Rituximab (INTRAVENOUS Maintenance) | 02 | null | 260028745 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008856 | 260005849 | null | 96.2 | Not known (9) | 2014-04-24 | 2014-04-28 | BENDAMUSTINE | 2 | N | 260028745 | RITUXIMAB |
| 260008857 | 260005850 | 1.67 | 75 | Curative (C) | 2017-12-24 | 2017-12-25 | Rituximab | 99 | null | 260028750 | CVP |
| 260008858 | 260005851 | 1.76 | 64 | null | 2016-08-22 | 2016-08-22 | Rituximab | 01 | null | 260028752 | ACE (GERM CELL) |
| 260008859 | 260012056 | 1.9 | 84 | Adjuvant (A) | 2017-03-06 | 2017-03-13 | RCEOP | N | N | 260028757 | RITUXIMAB |
| 260008860 | 260005852 | 1.7 | null | Curative (C) | 2018-10-22 | 2018-11-09 | Chlorambucil | Y | N | 260028758 | RITUXIMAB |
| 260008861 | 260005852 | null | 82 | Disease modification (D) | null | 2014-07-26 | Rituximab | null | null | 260028758 | ECX |
| 260008862 | 260005853 | null | 58 | Curative (C) | 2016-01-08 | 2016-02-06 | CISPLATIN + FLUOROURACIL + RT | N | Y | 260028760 | RITUXIMAB |
| 260008863 | 260005853 | 1.71 | 79.5 | Neo-adjuvant (N) | 2017-03-12 | 2017-03-19 | Rituximab | 02 | N | 260028760 | BEVACIZUMAB |
| 260008864 | 260005854 | 1.7 | 69.7 | Disease modification (D) | 2014-04-04 | 2014-04-16 | BENDAMUSTINE | Y | N | 260028763 | RITUXIMAB |
| 260008865 | 260005854 | 1.77 | 82.8 | Not known (9) | 2016-05-14 | 2016-06-11 | FCR | N | N | 260028763 | EP |
| 260008866 | 260005855 | 1.85 | 86.06 | Palliative (P) | 2015-08-01 | 2015-08-04 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028765 | BENDAMUSTINE |
| 260008867 | 260005855 | null | 75.9 | null | 2015-03-21 | 2015-03-22 | Rituximab | 02 | null | 260028765 | RITUXIMAB |
| 260008868 | 260005856 | 1.83 | 104 | Palliative (P) | 2017-05-19 | 2017-05-23 | GEMCITABINE + VINORELBINE | N | N | 260028767 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008869 | 260005856 | null | 80.9 | Adjuvant (A) | 2016-03-09 | 2016-03-10 | PACIFICO TRIAL | N | N | 260028767 | PACIFICO TRIAL |
| 260008870 | 260005857 | 1.55 | 82 | Disease modification (D) | 2015-01-31 | 2015-03-01 | Rituximab | 2 | Y | 260028770 | CHOP |
| 260008871 | 260005857 | 1.95 | null | Palliative (P) | null | 2016-08-17 | Rituximab | null | null | 260028770 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008872 | 260005858 | 1.65 | 56 | Palliative (P) | 2015-04-24 | 2015-05-15 | R Chlorambucil | N | N | 260028773 | RITUXIMAB |
| 260008873 | 260012063 | 1.6 | null | Curative (C) | 2014-01-12 | 2014-01-16 | Rituximab | N | N | 260028775 | BENDAMUSTINE |
| 260008874 | 260005859 | 1.8 | null | Curative (C) | 2015-05-19 | 2015-06-12 | Cyclophosphamide oral | N | Y | 260028776 | RITUXIMAB |
| 260008875 | 260005859 | null | null | Curative (C) | null | 2018-05-10 | Chlorambucil | N | N | 260028776 | RITUXIMAB |
| 260008876 | 260005860 | null | 110 | null | 2014-08-12 | 2014-08-12 | Bortezomib + Cyclophos + Dex | N | N | 260028782 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008877 | 260005860 | 1.79 | 80.3 | null | 2015-04-23 | 2015-04-23 | Rituximab | 02 | null | 260028782 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260008878 | 260005861 | null | 83.1 | Curative (C) | 2017-01-01 | 2017-01-01 | DHAP - R | Y | N | 260028785 | BENDAMUSTINE |
| 260008879 | 260005862 | null | 96 | Disease modification (D) | 2014-04-07 | 2014-04-08 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260028790 | RITUXIMAB |
| 260008880 | 260005863 | 0 | 114.3 | Palliative (P) | 2016-06-13 | 2016-06-21 | CAPECITABINE + RT | N | N | 260028791 | RITUXIMAB |
| 260008881 | 260012066 | 1.75 | null | Curative (C) | null | 2017-06-12 | CISPLATIN + ETOPOSIDE | N | Y | 260028792 | POMB |